Citigroup’s ProShares Ultra Health Care RXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-320
| Closed | -$17.9K | – | 5936 |
|
|
2024
Q3 | $17.9K | Hold |
320
| – | – | ﹤0.01% | 5208 |
|
|
2024
Q2 | $16.3K | Hold |
320
| – | – | ﹤0.01% | 5050 |
|
|
2024
Q1 | $17K | Hold |
320
| – | – | ﹤0.01% | 5082 |
|
|
2023
Q4 | $14.6K | Hold |
320
| – | – | ﹤0.01% | 5090 |
|
|
2023
Q3 | $13.2K | Hold |
320
| – | – | ﹤0.01% | 4489 |
|
|
2023
Q2 | $14.2K | Hold |
320
| – | – | ﹤0.01% | 5016 |
|
|
2023
Q1 | $13.7K | Hold |
320
| – | – | ﹤0.01% | 4635 |
|
|
2022
Q4 | $15.1K | Hold |
320
| – | – | ﹤0.01% | 4701 |
|
|
2022
Q3 | $12K | Hold |
320
| – | – | ﹤0.01% | 4934 |
|
|
2022
Q2 | $14K | Hold |
320
| – | – | ﹤0.01% | 5198 |
|
|
2022
Q1 | $16K | Hold |
320
| – | – | ﹤0.01% | 5283 |
|
|
2021
Q4 | $18K | Sell |
320
-400
| -56% | -$20.3K | ﹤0.01% | 5416 |
|
|
2021
Q3 | $34K | Hold |
720
| – | – | ﹤0.01% | 4968 |
|
|
2021
Q2 | $34K | Hold |
720
| – | – | ﹤0.01% | 5009 |
|
|
2021
Q1 | $29K | Sell |
720
-400
| -36% | -$15.8K | ﹤0.01% | 5031 |
|
|
2020
Q4 | $42K | Hold |
1,120
| – | – | ﹤0.01% | 6174 |
|
|
2020
Q3 | $37K | Hold |
1,120
| – | – | ﹤0.01% | 5782 |
|
|
2020
Q2 | $33K | Hold |
1,120
| – | – | ﹤0.01% | 6261 |
|
|
2020
Q1 | $25K | Sell |
1,120
-400
| -26% | -$11.5K | ﹤0.01% | 6544 |
|
|
2019
Q4 | $48K | Hold |
1,520
| – | – | ﹤0.01% | 6341 |
|
|
2019
Q3 | $37K | Hold |
1,520
| – | – | ﹤0.01% | 6323 |
|
|
2019
Q2 | $40K | Hold |
1,520
| – | – | ﹤0.01% | 6672 |
|
|
2019
Q1 | $40K | Hold |
1,520
| – | – | ﹤0.01% | 6518 |
|
|
2018
Q4 | $35K | Hold |
1,520
| – | – | ﹤0.01% | 6518 |
|
|
2018
Q3 | $44K | Hold |
1,520
| – | – | ﹤0.01% | 6629 |
|
|
2018
Q2 | $34K | Hold |
1,520
| – | – | ﹤0.01% | 6586 |
|
|
2018
Q1 | $33K | Hold |
1,520
| – | – | ﹤0.01% | 6445 |
|
|
2017
Q4 | $34K | Buy |
+1,520
| New | +$33K | ﹤0.01% | 6435 |
|
|
2014
Q3 | – | Sell |
-528
| Closed | -$6K | – | 7259 |
|
|
2014
Q2 | $6K | Buy |
+528
| New | +$5.99K | ﹤0.01% | 6389 |
|
|
2013
Q4 | – | Sell |
-648
| Closed | -$6K | – | 7127 |
|
|
2013
Q3 | $6K | Buy |
+648
| New | +$5.46K | ﹤0.01% | 6367 |
|
Other funds holding RXL
Citigroup's RXL Position: Q4 2024 in Review
Citigroup sold out of ProShares Ultra Health Care (RXL) in Q4 2024, closing a stake of 320 shares — an estimated $17.9K sold.
Citigroup first reported a position in RXL in Q3 2013 and held it in 30 quarters. The position peaked at $48K in Q4 2019. 16 funds tracked by Wall St. Rank hold RXL as of Q4 2024.
- Citigroup reported no remaining ProShares Ultra Health Care position as of Q4 2024 after selling out during the quarter.
- Citigroup sold 320 ProShares Ultra Health Care shares in Q4 2024, an estimated $17.9K.
- Citigroup first reported a position in ProShares Ultra Health Care in Q3 2013 and held it in 30 quarters.
- Citigroup's ProShares Ultra Health Care position peaked at $48K in Q4 2019.
- 16 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q4 2024.
Based on Citigroup's 13F filing for Q4 2024, filed 12 Feb 2025.